发明名称 <i>Irvingia gabonensis </i>to treat and prevent metabolic syndrome and reduce total cholesterol, LDL cholesterol, blood glucose, C-reactive protein, and leptin levels and increasing adiponectin levels
摘要 In one embodiment, a method is provided for lowering C-reactive protein levels in a mammal. The method comprises administering a composition containing an effective amount of Irvingia gabonensis seed to a mammal to reduce C-reactive protein levels in the mammal. Other embodiments include, among other things, lowering leptin levels, increasing adiponectin levels, reducing body weight, decreasing LDL and total cholesterol levels, increasing fat loss, and reducing waist size in a mammal using administering a composition containing an effective amount of Irvingia gabonensis.
申请公布号 US9480724(B2) 申请公布日期 2016.11.01
申请号 US201414242749 申请日期 2014.04.01
申请人 Oben Julius Enyoug 发明人 Oben Julius Enyoug
分类号 A61K36/00;A61K36/185 主分类号 A61K36/00
代理机构 Partners Law Group, Inc. 代理人 Hassid Steve P.;Partners Law Group, Inc.
主权项 1. A method of decreasing LDL and total cholesterol levels in a human, the method comprising: administering a composition containing about 300 mg of Irvingia gabonensis seed extract to a human once daily to decrease LDL cholesterol levels by at least 27% in the human and total cholesterol levels by at least 26% in the human.
地址 Cameroon CM